You are here: Home: BCU Surgeons 1 | 2006: J Michael Dixon, MD: Select Publications

SELECT PUBLICATIONS

Delozier T et al. Optimal duration of adjuvant tamoxifen (TAM) in early breast cancer (EBC): Ten year results of a randomized trial (TAM-01) of the FNCLCC Breast Group. San Antonio Breast Cancer Symposium 2005;Abstract 14.

Dowsett M et al; on behalf of the IMPACT Trialists. Ki67 after 2 weeks endocrine treatment predicts relapse-free survival (RFS) in the IMPACT trial. Presentation. San Antonio Breast Cancer Symposium 2005;Abstract 45.

Faratian D et al. Effects of letrozole and anastrozole on ductal carcinoma in situ (DCIS): Results from a randomised trial. San Antonio Breast Cancer Symposium 2005;Abstract 6041.

Goss PE et al. Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: Updated findings from NCIC CTG MA.17. J Natl Cancer Inst 2005;97(17):1262-71. Abstract

Murray J et al. Letrozole and anastrozole: A pre-operative study of their effects on ERpositive breast cancers in postmenopausal women. San Antonio Breast Cancer Symposium 2004;Abstract 406.

 

 

 

 

Search our Site:

Home · Search